Video Experimental Relacionado
Updated: Jul 13, 2026
11:28
Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus
Published on: October 7, 2011
Epidemiología, patogénesis, prevención y tratamiento del VIH/SIDA
Viviana Simon1, David D Ho, Quarraisha Abdool Karim
1Aaron Diamond AIDS Research Center, The Rockefeller University, New York, NY, USA. viviana.simon@mssm.edu
Lancet (London, England)
|August 8, 2006
Resumen
La pandemia del virus de la inmunodeficiencia humana tipo 1 (VIH-1) sigue siendo una crisis de salud mundial. Si bien los tratamientos manejan el SIDA, todavía se necesita una cura o vacuna para el VIH-1, especialmente en las regiones de alta carga.
Área de la Ciencia:
- Salud Global La salud global.
- Enfermedades infecciosas Enfermedades infecciosas.
- Virología Virología.
Sus antecedentes:
- La pandemia del virus de la inmunodeficiencia humana tipo 1 (VIH-1) se presenta como una compleja crisis mundial de salud pública.
- A pesar de los avances en la comprensión de la replicación, la patogénesis y la transmisión del VIH-1, una cura definitiva o una vacuna protectora sigue siendo difícil de alcanzar.
- La terapia antirretroviral ha cambiado el Síndrome de Inmunodeficiencia Adquirida (SIDA) a una condición crónica manejable en ciertas áreas, pero este progreso no es universal.
Objetivo del estudio:
- Proporcionar una actualización completa sobre la epidemiología del VIH-1.
- Revisar los conocimientos actuales sobre la patogénesis del VIH-1 y la dinámica de transmisión.
- Resumir los avances en las estrategias de tratamiento y prevención del VIH-1.
Principales métodos:
- Revisión de los datos epidemiológicos actuales sobre el VIH-1.
- Análisis de investigaciones recientes sobre la patogénesis del VIH-1.
- Síntesis de información sobre la eficacia del tratamiento antirretroviral y las intervenciones de prevención.
Principales resultados:
- Las epidemias de VIH-1 son diversas y varían significativamente entre y dentro de los países.
- La comprensión de la replicación viral, la manipulación y la latencia ha mejorado.
- El tratamiento antirretroviral ha manejado con éxito el SIDA en muchos entornos, pero las disparidades persisten a nivel mundial.
Conclusiones:
- La pandemia del VIH-1 requiere investigación continua e intervenciones personalizadas para diversas epidemias globales.
- El acceso equitativo a un tratamiento y prevención efectivos es crucial para abordar la carga desproporcionada del VIH-1 en ciertas regiones.
- Se necesitan esfuerzos continuos para desarrollar una cura y una vacuna protectora para el VIH-1.
Videos de Conceptos Relacionados
00:57Viral Recombination
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
00:36Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
01:20Infection
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
01:28Infectious Diseases and Their Occurrence
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
01:23Investigation of Disease Outbreaks
Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
01:23Genital Herpes
Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...